Company intelligence / Profile preview

MainPointe Pharmaceuticals

Louisville, Kentucky, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

MainPointe Pharmaceuticals sells and distributes consumer health brands and over-the-counter (OTC) drugs, with products such as Nexafed, Slo-Niacin, and Tuxarin ER commercially available in the United States. Their pipeline includes approved combination drugs such as chlorpheniramine maleate/codeine phosphate for symptomatic cold relief, and the company launched nine products since 2017. Clinical-stage research and recent partnerships focus on OTC, not novel prescription therapeutics.

Therapeutic areas: ImmunologyPulmonologyInfectious DiseasesMetabolic DisordersOther
Modalities: Small molecule
Industry: Biotech

Partnerships

RepliCel Life SciencesMission Pharmacal

Beyond the preview

Go deeper on MainPointe Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MainPointe Pharmaceuticals.

Explore the full profile